Abstract

These results demonstrate that the benefit of cholesterol-lowering therapy extends to the majority of patients with coronary disease who have average cholesterol levels.

Keywords

PravastatinMedicineMyocardial infarctionPlaceboInternal medicineCardiologyConfidence intervalCholesterolClinical endpointRandomized controlled trial

Affiliated Institutions

Related Publications

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever , Björn Dahlöf , Neil R Poulter +11 more

The lowering of cholesterol concentrations in individuals at high risk of cardiovascular disease improves outcome. No study, however, has assessed benefits of cholesterol loweri...

2003 The Lancet 3773 citations

Publication Info

Year
1996
Type
article
Volume
335
Issue
14
Pages
1001-1009
Citations
7456
Access
Closed

External Links

View on DOI.org

Social Impact

Altmetric
PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

7456
OpenAlex

Cite This

Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moyé et al. (1996). The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels. New England Journal of Medicine , 335 (14) , 1001-1009. https://doi.org/10.1056/nejm199610033351401

Identifiers

DOI
10.1056/nejm199610033351401